Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126948212 | 12694821 | 2 | F | 2016 | 20160829 | 20160829 | 20160908 | EXP | US-JNJFOC-20160719659 | PHARMACYCLICS | 0.00 | E | M | Y | 0.00000 | 20160908 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126948212 | 12694821 | 1 | SS | IMBRUVICA | IBRUTINIB | 1 | Oral | Y | N | 0 | 420 | MG | CAPSULE | QD | |||||
| 126948212 | 12694821 | 2 | PS | IMBRUVICA | IBRUTINIB | 1 | Oral | Y | N | 205552 | 280 | MG | CAPSULE | QD | |||||
| 126948212 | 12694821 | 3 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | U | 0 | ||||||||||
| 126948212 | 12694821 | 4 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | 0 | ||||||||||||
| 126948212 | 12694821 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 126948212 | 12694821 | 6 | C | GEMFIBROZIL. | GEMFIBROZIL | 1 | 0 | ||||||||||||
| 126948212 | 12694821 | 7 | C | ATENOLOL. | ATENOLOL | 1 | 0 | ||||||||||||
| 126948212 | 12694821 | 8 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 126948212 | 12694821 | 9 | C | IRON | IRON | 1 | 0 | ||||||||||||
| 126948212 | 12694821 | 10 | C | OSTEO BI-FLEX | CHONDROITIN SULFATE AGLUCOSAMINE | 1 | 0 | ||||||||||||
| 126948212 | 12694821 | 11 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
| 126948212 | 12694821 | 12 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 126948212 | 12694821 | 13 | C | DOXAZOSIN MESYLATE. | DOXAZOSIN MESYLATE | 1 | 0 | ||||||||||||
| 126948212 | 12694821 | 14 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126948212 | 12694821 | 1 | Chronic lymphocytic leukaemia |
| 126948212 | 12694821 | 2 | Chronic lymphocytic leukaemia |
| 126948212 | 12694821 | 3 | Blood uric acid increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126948212 | 12694821 | OT |
| 126948212 | 12694821 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126948212 | 12694821 | Arthralgia | |
| 126948212 | 12694821 | Blood potassium increased | |
| 126948212 | 12694821 | Blood uric acid increased | |
| 126948212 | 12694821 | Contusion | |
| 126948212 | 12694821 | Diarrhoea | |
| 126948212 | 12694821 | Haemorrhage | |
| 126948212 | 12694821 | Myalgia | |
| 126948212 | 12694821 | Platelet count increased | |
| 126948212 | 12694821 | Pleural effusion | |
| 126948212 | 12694821 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126948212 | 12694821 | 1 | 20160711 | 0 | ||
| 126948212 | 12694821 | 2 | 20160812 | 0 |